http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014142780-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f19b9a711398eecbe5238d5c692e6e2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d70d584881a267e96193f8d29853ad2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b347c1b6d3a494cb21b8d1f7a936f6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fb1a4d24b2fcc63e774750027f4379a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
| filingDate | 2013-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6471c61bba6b7ab1a953e2cd7d9b246 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bdc2c3427602d92b866f320584e5e38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748b5f5834212bf0bf33243361f7d5b4 |
| publicationDate | 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014142780-A1 |
| titleOfInvention | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
| abstract | Methods of treating, reducing the incidence of, and/or preventing an ischemic event in a patient undergoing percutaneous coronary intervention (PCI), comprising administering to the patient a pharmaceutical composition comprising cangrelor. The method may further comprise administering an additional therapeutic agent to the patient, the additional therapeutic agent comprising a P2Yi2 inhibitor. Pharmaceutical compositions useful for treating, reducing the incidence of, and/or preventing an ischemic event in a patient undergoing PCI. The pharmaceutical compositions comprise cangrelor. Methods of preparing a pharmaceutical composition for treating, reducing the incidence of, and/or preventing an ischemic event in a patient undergoing PCI, comprising admixing cangrelor with one or more pharmaceutically acceptable excipients. An ischemic event may include stent thrombosis, myocardial infarction, ischemia-driven revascularization, and mortality. |
| priorityDate | 2013-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.